Related Experiment Video
Updated: Jul 17, 2026
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Germany's disease management program: improving outcomes in congestive heart failure.
Stefan Kottmair1, Christian Frye, Dieter J Ziegenhagen
1ArztPartner almeda, Munich, Germany.
Health Care Financing Review
|February 10, 2007
Summary
A new disease management program for congestive heart failure (CHF) improved patient health outcomes and reduced hospital readmissions. This comprehensive approach led to significant cost savings for health insurance providers.
Area of Science:
- Health Services Research
- Cardiology
- Health Economics
Background:
- Hospital admissions for congestive heart failure (CHF) represent a substantial healthcare expenditure.
- Effective disease management programs are crucial for improving patient outcomes and reducing healthcare costs.
Purpose of the Study:
- To evaluate the effectiveness of a comprehensive disease management program for congestive heart failure (CHF) patients.
- To assess the program's impact on health outcomes, rehospitalization rates, and associated costs.
Main Methods:
- A disease management program incorporating care calls, educational materials, telemetric monitoring, and health reports was implemented.
- Data from 909 members across six insurance companies were analyzed.
- Routine evaluation utilized medical data warehouse software and claims data in a pre/post study design.
Main Results:
- The program demonstrated improvements in patient health outcomes and care processes.
- Economical evaluation of claims data indicated significant cost savings.
- Reduced rehospitalization rates were observed post-implementation.
Conclusions:
- A comprehensive CHF disease management program can effectively improve patient health and reduce healthcare costs.
- The integration of telemetric monitoring and regular health reporting contributes to program success.
- This model offers a viable strategy for health insurance companies to manage CHF and control expenditures.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...